サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1458631

AI心臓モニタリングおよび診断の世界市場レポート 2024年

Cardiac AI Monitoring And Diagnostics Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
AI心臓モニタリングおよび診断の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

AI心臓モニタリングおよび診断市場規模は、今後数年で飛躍的な成長が見込まれます。2028年には、CAGR26.4％で43億7,000万米ドルに成長します。予測期間中に予想される成長は、ウェアラブルデバイスやIoT（モノのインターネット）デバイスの拡大、遠隔医療と遠隔モニタリングソリューションの採用拡大、心臓ケアにおけるビッグデータ解析と予測モデリングの統合、患者中心のケアと遠隔患者エンゲージメントイニシアチブの重視、継続的なヘルスケアインフラ整備など、さまざまな要因によるものと考えられます。予測期間に予想される主な動向には、ウェアラブルデバイスとAIの統合、AI機能を活用した個別化リスク評価と治療計画、心血管イベント予測のための予測分析の利用、包括的分析のためのマルチモーダルデータソースの統合、ヘルスケアエコシステム内での相互運用性とデータ統合基準の重視などが含まれます。

心血管疾患の有病率の増加は、当面のAI心臓モニタリングおよび診断市場の成長を促進すると予測されます。心血管疾患には、冠動脈疾患、脳卒中、心不全など、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。AI心臓モニタリングおよび診断は、これらの疾患の早期発見、リスク評価、個別化治療において重要な役割を果たし、最終的には患者の予後改善につながります。例えば、米国疾病予防管理センター（CDC）が2023年5月に発表したデータでは、米国における心臓疾患に起因する死亡者数の増加が懸念されており、高度な心臓モニタリングおよび診断ソリューションの差し迫った必要性が浮き彫りになっています。

AI心臓モニタリングおよび診断市場で事業を展開する新興国市場は、人工知能ベースの植込み型心臓モニターなど、技術主導型の医療機器の開発に力を注いでおり、同市場での地位を確固たるものにしています。人工知能ベースの植え込み型心臓モニターは、心臓血管ヘルスケアにおける画期的なイノベーションであり、心機能の継続的かつ正確なモニタリングを提供します。例えば、2023年5月、ドイツに本社を置く著名な心血管生物医学研究・技術企業であるBiotronikは、BIOMONITOR IV植込み型心臓モニター（ICM）のFDA承認を発表しました。人工知能を搭載したBIOTRONIKの最先端のSmartECGアルゴリズムを搭載したBIOMONITOR IV ICMは、心臓モニタリングの精度に新たな基準を打ち立てます。高度なアルゴリズムを活用することで、SmartECGテクノロジーは、本物の心臓エピソードの高い検出率を維持しながら、誤認識を大幅に低減します。この検出精度の向上により、ヘルスケア専門家は迅速かつ正確な診断を行うことができ、患者ケアと転帰を最適化することができます。さらに、BIOMONITOR IV ICMは、早発性心室収縮（PVC）や早発性心房収縮（PAC）といった異なるタイプの心収縮を区別し、診断能力と臨床的有用性をさらに高めます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のAI心臓モニタリングおよび診断市場、タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 心臓診断
  • 心臓モニタリング
  • 世界のAI心臓モニタリングおよび診断市場、製品別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • ソフトウェア
  • ハードウェア
  • 世界のAI心臓モニタリングおよび診断市場、アプリケーション別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 虚血性心疾患または冠動脈疾患（CAD）
  • 心不整脈
  • 虚血性脳卒中
  • その他のアプリケーション
  • 世界のAI心臓モニタリングおよび診断市場、エンドユーザー別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 病院
  • 診断センター
  • その他のエンドユーザー

第7章 地域別・国別分析

  • 世界のAI心臓モニタリングおよび診断市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
  • 世界のAI心臓モニタリングおよび診断市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • AI心臓モニタリングおよび診断市場の競合情勢
  • AI心臓モニタリングおよび診断市場企業プロファイル
    • Abbott Laboratories
    • Medtronic plc
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • GE HealthCare Technologies Inc.

第31章 その他の大手企業と革新的企業

  • Boston Scientific Corporation
  • ZOLL Medical Corporation
  • Canon Medical Systems Corporation
  • Biotronik SE &Co. KG
  • iRhythm Technologies Inc.
  • Tempus Labs Inc.
  • Viz.ai Inc.
  • HeartFlow Inc.
  • Aidoc
  • Eko Devices Inc.
  • CardioFocus Inc.
  • Circle Cardiovascular Imaging Inc.
  • Ultromics Limited.
  • Cathworks
  • Medicalgorithmics SA

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的分析

第36章 付録

目次
Product Code: r16612

Cardiac AI monitoring and diagnostics involve the application of artificial intelligence (AI) technologies in the field of cardiology to monitor and diagnose various cardiovascular conditions. This utilizes advanced algorithms and machine learning techniques to analyze data from cardiac monitoring devices, such as electrocardiograms (ECGs).

The main categories of cardiac AI monitoring and diagnostics are cardiac diagnostics and cardiac monitoring. Cardiac diagnostics encompass methods and procedures used to identify heart conditions associated with unhealthy or pathologic heart function. The products in this category include software and hardware used in applications such as ischemic heart diseases or coronary artery disease (CAD), cardiac arrhythmias, ischemic stroke, and others. End users of these cardiac AI solutions include hospitals, diagnostic centers, and various healthcare facilities.

The cardiac AI monitoring and diagnostics research report is one of a series of new reports from The Business Research Company that provides cardiac AI monitoring and diagnostics market statistics, including the cardiac AI monitoring and diagnostics industry's global market size, regional shares, competitors with an cardiac AI monitoring and diagnostics market share, detailed cardiac AI monitoring and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac AI monitoring and diagnostics industry. This cardiac AI monitoring and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac AI monitoring and diagnostics market size has grown exponentially in recent years. It will grow from $1.35 billion in 2023 to $1.71 billion in 2024 at a compound annual growth rate (CAGR) of 26.6%. The growth observed in the historical period can be attributed to various factors, including demographic changes with an aging population, an increase in remote patient monitoring solutions, higher healthcare expenditure, the execution of clinical research and validation studies, and a heightened focus on preventive healthcare measures.

The cardiac AI monitoring and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $4.37 billion in 2028 at a compound annual growth rate (CAGR) of 26.4%. The anticipated growth in the forecast period can be attributed to various factors, including the expansion of wearable and IoT (Internet of Things) devices, an increasing adoption of telemedicine and remote monitoring solutions, integration of big data analytics and predictive modeling in cardiac care, a focus on patient-centered care and remote patient engagement initiatives, and ongoing healthcare infrastructure development. Key trends expected in the forecast period encompass the integration of AI with wearable devices, personalized risk assessment and treatment planning leveraging AI capabilities, the use of predictive analytics for forecasting cardiovascular events, integration of multimodal data sources for comprehensive analysis, and the emphasis on interoperability and data integration standards within the healthcare ecosystem.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the cardiac AI monitoring and diagnostics market in the foreseeable future. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, stroke, and heart failure. Cardiac AI monitoring and diagnostics play a crucial role in the early detection, risk assessment, and personalized treatment of these conditions, ultimately leading to improved patient outcomes. For instance, data from the Centers for Disease Control and Prevention (CDC) in May 2023 revealed a concerning rise in the number of deaths attributed to heart disease in the United States, underlining the pressing need for advanced cardiac monitoring and diagnostic solutions.

Leading companies operating in the cardiac AI monitoring and diagnostics market are directing their efforts towards the development of technology-driven medical devices, such as artificial intelligence-based implantable cardiac monitors, to solidify their position in the market. Artificial intelligence-based implantable cardiac monitors represent a groundbreaking innovation in cardiovascular healthcare, offering continuous and accurate monitoring of cardiac function. For example, in May 2023, Biotronik, a renowned cardiovascular biomedical research and technology company based in Germany, announced the FDA approval of its BIOMONITOR IV implantable cardiac monitor (ICM). Equipped with BIOTRONIK's cutting-edge SmartECG algorithm powered by artificial intelligence, the BIOMONITOR IV ICM sets a new standard in cardiac monitoring accuracy. By leveraging advanced algorithms, the SmartECG technology significantly reduces false identifications while maintaining a high detection rate for genuine cardiac episodes. This enhancement in detection accuracy empowers healthcare professionals to make prompt and precise diagnoses, thus optimizing patient care and outcomes. Furthermore, the BIOMONITOR IV ICM distinguishes between different types of cardiac contractions, such as premature ventricular contractions (PVCs) and premature atrial contractions (PACs), further enhancing its diagnostic capabilities and clinical utility.

In January 2022, Koninklijke Philips N.V., a healthcare technology company headquartered in the Netherlands, completed the acquisition of Cardiologs Technologies SAS, a medical technology company based in France, for an undisclosed sum. This strategic move positions Cardiologs to enhance Philips' cardiac monitoring and diagnostics portfolio through the integration of innovative software solutions, electrocardiogram (ECG) analysis, and reporting services. Cardiologs Technologies SAS specializes in optimizing cardiac diagnostics through the utilization of artificial intelligence (AI) and cloud technologies, aligning with Philips' commitment to advancing healthcare through cutting-edge innovations.

Major companies operating in the cardiac ai monitoring and diagnostics market report are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, ZOLL Medical Corporation, Canon Medical Systems Corporation, Biotronik SE & Co. KG, iRhythm Technologies Inc., Tempus Labs Inc., Viz.ai Inc., HeartFlow Inc., Aidoc, Eko Devices Inc., CardioFocus Inc., Circle Cardiovascular Imaging Inc., Ultromics Limited., Cathworks, Medicalgorithmics S.A., Nanox.AI Ltd, Cardiac Insight Inc., CardioSecur GmbH, Cardionomic Inc., HeartSciences, CardioComm Solutions Inc., CardioDiagnostics Inc.

North America was the largest region in the cardiac AI monitoring and diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac ai monitoring and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac ai monitoring and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac AI monitoring and diagnostics market consists of revenues earned by entities by providing services such as ST-segment monitoring, arrhythmia detection, heart rate variability analysis, risk stratification, and echocardiogram interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac AI monitoring and diagnostics market also includes sales of echocardiography devices, cardiac MRI and CT analysis, electrocardiogram (ECG) analysis tools, and wearable devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac AI Monitoring And Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac AI monitoring and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac AI monitoring and diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac AI monitoring and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Cardiac Diagnostics; Cardiac Monitoring
  • 2) By Product: Software; Hardware
  • 3) By Application: Ischemic Heart Diseases Or Coronary Artery Disease (CAD); Cardiac Arrhythmias; Ischemic Stroke; Other Applications
  • 4) By End Users: Hospitals; Diagnostic Centers; Other End Users
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac AI Monitoring And Diagnostics Market Characteristics

3. Cardiac AI Monitoring And Diagnostics Market Trends And Strategies

4. Cardiac AI Monitoring And Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cardiac AI Monitoring And Diagnostics Market Size and Growth

  • 5.1. Global Cardiac AI Monitoring And Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cardiac AI Monitoring And Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cardiac AI Monitoring And Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cardiac AI Monitoring And Diagnostics Market Segmentation

  • 6.1. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiac Diagnostics
  • Cardiac Monitoring
  • 6.2. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Software
  • Hardware
  • 6.3. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ischemic Heart Diseases Or Coronary Artery Disease (CAD)
  • Cardiac Arrhythmias
  • Ischemic Stroke
  • Other Applications
  • 6.4. Global Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Other End Users

7. Cardiac AI Monitoring And Diagnostics Market Regional And Country Analysis

  • 7.1. Global Cardiac AI Monitoring And Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cardiac AI Monitoring And Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market

  • 8.1. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cardiac AI Monitoring And Diagnostics Market

  • 9.1. China Cardiac AI Monitoring And Diagnostics Market Overview
  • 9.2. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cardiac AI Monitoring And Diagnostics Market

  • 10.1. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cardiac AI Monitoring And Diagnostics Market

  • 11.1. Japan Cardiac AI Monitoring And Diagnostics Market Overview
  • 11.2. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cardiac AI Monitoring And Diagnostics Market

  • 12.1. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cardiac AI Monitoring And Diagnostics Market

  • 13.1. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cardiac AI Monitoring And Diagnostics Market

  • 14.1. South Korea Cardiac AI Monitoring And Diagnostics Market Overview
  • 14.2. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cardiac AI Monitoring And Diagnostics Market

  • 15.1. Western Europe Cardiac AI Monitoring And Diagnostics Market Overview
  • 15.2. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cardiac AI Monitoring And Diagnostics Market

  • 16.1. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cardiac AI Monitoring And Diagnostics Market

  • 17.1. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cardiac AI Monitoring And Diagnostics Market

  • 18.1. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cardiac AI Monitoring And Diagnostics Market

  • 19.1. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cardiac AI Monitoring And Diagnostics Market

  • 20.1. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cardiac AI Monitoring And Diagnostics Market

  • 21.1. Eastern Europe Cardiac AI Monitoring And Diagnostics Market Overview
  • 21.2. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cardiac AI Monitoring And Diagnostics Market

  • 22.1. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cardiac AI Monitoring And Diagnostics Market

  • 23.1. North America Cardiac AI Monitoring And Diagnostics Market Overview
  • 23.2. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cardiac AI Monitoring And Diagnostics Market

  • 24.1. USA Cardiac AI Monitoring And Diagnostics Market Overview
  • 24.2. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cardiac AI Monitoring And Diagnostics Market

  • 25.1. Canada Cardiac AI Monitoring And Diagnostics Market Overview
  • 25.2. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cardiac AI Monitoring And Diagnostics Market

  • 26.1. South America Cardiac AI Monitoring And Diagnostics Market Overview
  • 26.2. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cardiac AI Monitoring And Diagnostics Market

  • 27.1. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cardiac AI Monitoring And Diagnostics Market

  • 28.1. Middle East Cardiac AI Monitoring And Diagnostics Market Overview
  • 28.2. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cardiac AI Monitoring And Diagnostics Market

  • 29.1. Africa Cardiac AI Monitoring And Diagnostics Market Overview
  • 29.2. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cardiac AI Monitoring And Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac AI Monitoring And Diagnostics Market Competitive Landscape
  • 30.2. Cardiac AI Monitoring And Diagnostics Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic plc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Koninklijke Philips N.V.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GE HealthCare Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cardiac AI Monitoring And Diagnostics Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. ZOLL Medical Corporation
  • 31.3. Canon Medical Systems Corporation
  • 31.4. Biotronik SE & Co. KG
  • 31.5. iRhythm Technologies Inc.
  • 31.6. Tempus Labs Inc.
  • 31.7. Viz.ai Inc.
  • 31.8. HeartFlow Inc.
  • 31.9. Aidoc
  • 31.10. Eko Devices Inc.
  • 31.11. CardioFocus Inc.
  • 31.12. Circle Cardiovascular Imaging Inc.
  • 31.13. Ultromics Limited.
  • 31.14. Cathworks
  • 31.15. Medicalgorithmics S.A.

32. Global Cardiac AI Monitoring And Diagnostics Market Competitive Benchmarking

33. Global Cardiac AI Monitoring And Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cardiac AI Monitoring And Diagnostics Market

35. Cardiac AI Monitoring And Diagnostics Market Future Outlook and Potential Analysis

  • 35.1 Cardiac AI Monitoring And Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cardiac AI Monitoring And Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cardiac AI Monitoring And Diagnostics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer